Go back to News
NEWS
GA_P advises Giochi Preziosi on the acquisition of Muñecas Arias
GA_P has advised the Italian toy company Giochi Preziosi, which is already the leader in Spain in manufacturing and sales after acquiring Famosa in 2019, on the acquisition of another historic Spanish brand, the Alicante-based company Muñecas Arias. With this acquisition, the group strengthens its position in the dolls category at European level.
The Giochi Preziosi Group, an Italian multinational with more than 40 years of history, is currently one of the largest European players in the traditional toy industry.
Advised on the transaction: Pablo Fernández Cortijo, partner of Commercial, Mónica Ojeda, associate of Commercial, Mònica Montoro, PMA of Commercal, Lourdes Escassi, Of Counsel of Employment, Delia Castaños, Jesús Tallos, associates of Employment, Silvana Zarzar, associate of Employment, Isabela Crespo, associate of Industrial, Intellectual Property and Technology Elisa Gómez-Bernardo, associate of Industrial, Intellectual Property and Technology, Marta Rey and Ester Abascal, associates of public law.
The Giochi Preziosi Group, an Italian multinational with more than 40 years of history, is currently one of the largest European players in the traditional toy industry.
Advised on the transaction: Pablo Fernández Cortijo, partner of Commercial, Mónica Ojeda, associate of Commercial, Mònica Montoro, PMA of Commercal, Lourdes Escassi, Of Counsel of Employment, Delia Castaños, Jesús Tallos, associates of Employment, Silvana Zarzar, associate of Employment, Isabela Crespo, associate of Industrial, Intellectual Property and Technology Elisa Gómez-Bernardo, associate of Industrial, Intellectual Property and Technology, Marta Rey and Ester Abascal, associates of public law.
Lawyer mentioned
Pablo Fernández Cortijo – Partner
Lourdes Escassi – Counsel
See all lawyers
See less lawyers
Category
Deal
Areas and sectors
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
30 Apr, 2026
Pharma & Healthcare No. 48
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
29 Apr, 2026
Limitation of a patent and the Unified Patent Court’s ‘long arm’
We analyse the problems that arise when a claim is filed with the UPC for infringement of a unitary patent and, at the same time, for infringement of the validation of the basic European patent in States that are not party to the Agreement on a Unified Patent Court, and the claimant solely limits the unitary patent (because the defendant only files a counterclaim for revocation of the unitary patent with said court, but does not initiate any parallel revocation proceedings with the competent national court against the validations of the basic European patent in States that are not party to said agreement).
PUBLICATION
21 Apr, 2026
The 28th Corporate Regime: the EU Inc.
The Proposal for a Regulation of the European Parliament and of the Council on the 28th Regime Corporate Legal Framework – ‘EU Inc.’, dated 18 March 2026, introduces a new form of European private limited company. Originally envisaged for start-ups and scale-ups, it has been decided to allow its adoption by all companies. There is no minimum share capital requirement; shares may have no nominal value and may carry multiple voting rights, among other features. The Commission is expected to approve model articles of association so that a company can be incorporated online in less than forty-eight hours and for less than one hundred euros.
PUBLICATION
17 Apr, 2026
Can a framework agreement lacking an exclusivity or minimum orders clause be discharged by breach?
All cases decided by the Supreme Court and their specific details are discussed. There is no single solution to the problem of terminating a framework supply of services agreement without an exclusivity clause or a minimum purchases obligation.
PUBLICATION
26 Mar, 2026
Royal Decree-law 7/2026: measures in support of electro-intensive consumers
Reduced connection charges for electro-intensive consumers and the Fund for the Promotion of Industrial Decarbonization will help improve the industrial sector's competitiveness in the current economic climate.
PUBLICATION
12 Mar, 2026
European reform of the sustainability reporting regime under Directive (EU) 2026/470: consequences of its non-transposition into domestic law
Directive (EU) 2026/470 (Omnibus I) has been published, limiting the obligation to prepare a sustainability report to public-interest entities with more than 1,000 employees and a net turnover of more than €450 million during the preceding financial year, as well as to parent companies of a large group that exceed these figures on a consolidated basis. The Directive amends the audit directive, the accounting directive, the corporate sustainability reporting directive (CSRD) and the corporate sustainability due diligence directive (CSDDD).
PUBLICATION
11 Mar, 2026
Uncertificated share pledge creation, enforceability and avoidance (Supreme Court Judgment no.183/2026 of 10 February)
In Judgment no. 183/2026, of 10 February, the Supreme Court analysed the requirements for the validity and enforceability of an uncertificated registered share pledge and examined the conditions for its avoidance in the context of insolvency proceedings.
PUBLICATION
06 Mar, 2026
The long arm of the Unified Patent Court based on the "event giving rise to the infringement" and considerations on the application of lex loci protectionis
This paper analyses the decision of the Mannheim Local Division of 2 October 2025, where the Unified Patent Court (UPC) justifies its jurisdiction on the basis of shipment of products from a UPC territory by company listed as authorized representative in the EC and UK markets as event giving rise to damage. Furthermore, although the applicable law with regard to the infringement of the European patent validated in States that are not party to the Agreement on a Unified Patent Court is the national law of those States, with regard to the scope of patent protection, the UPC imposes on the defendant—unduly—the burden of proving the specifics of national law.
PUBLICATION
26 Feb, 2026
Pharma & Healthcare No. 47
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.